SEC Form 4 · accession 0001179110-15-003862
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Swisher Jr.
Officer — President and CEO · Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 2, 2015 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | A | 30,330 | $0.00 | A | 188,098 | D | |
| Common Stock | Feb 27, 2015 | F | 12,274 | $2.22 | D | 175,824 | D | |
| Common StockF2 | holding | — | — | — | 129,136 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The number of shares includes 3,695 shares that the reporting person acquired from an ESPP purchase on 11/28/14.
- F2The shares are held by the Swisher Revocable Trust for which reporting person is the Trustee